ICNAS - Institute for Nuclear Sciences Applied to Health Revenue and Competitors

Coimbra, PRT

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • ICNAS - Institute for Nuclear Sciences Applied to Health's estimated annual revenue is currently $6.2M per year.(i)
  • ICNAS - Institute for Nuclear Sciences Applied to Health's estimated revenue per employee is $91,800

Employee Data

  • ICNAS - Institute for Nuclear Sciences Applied to Health has 68 Employees.(i)
  • ICNAS - Institute for Nuclear Sciences Applied to Health grew their employee count by 6% last year.

ICNAS - Institute for Nuclear Sciences Applied to Health's People

NameTitleEmail/Phone
1
Security OfficerReveal Email/Phone
2
R&D Support Officer | Técnico SuperiorReveal Email/Phone
3
Head Project Management UnitReveal Email/Phone
4
R&D Support Officer - Divisão de Apoio e Promoção da InvestigaçãoReveal Email/Phone
5
R&D Support OfficerReveal Email/Phone
6
Técnica Superior / Project managerReveal Email/Phone
7
Project ManagerReveal Email/Phone
8
Gestora de Projetos | Project ManagerReveal Email/Phone
9
Project ManagerReveal Email/Phone
10
Gestora Financeira_Projetos de inovaçãoReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.6M3043%N/AN/A
#2
$2.6M3043%N/AN/A
#3
$0.7M12100%N/AN/A
#4
$6.7M7316%N/AN/A
#5
$0.7M11450%N/AN/A
#6
$3.3M3831%N/AN/A
#7
$29.7M2654%N/AN/A
#8
$6.2M686%N/AN/A
#9
$2.1M2938%N/AN/A
Add Company

What Is ICNAS - Institute for Nuclear Sciences Applied to Health?

ICNAS is a medical imaging research institution of the University of Coimbra that congregates the main medical imaging modalities (PET, MRI, CT, EEG) in the same building, including cyclotron and radiochemistry facilities.

keywords:N/A

N/A

Total Funding

68

Number of Employees

$6.2M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$25.3M7346%N/A
#2
$12.3M7724%N/A
#3
$13.8M7961%N/A
#4
$12M8036%N/A
#5
$11.2M8027%N/A